Literature DB >> 3282712

Human IgG subclasses and their relation to carbohydrate antigen immunocompetence.

M G Scott1, P G Shackelford, D E Briles, M H Nahm.   

Abstract

Human IgG responses to carbohydrate antigens, such as those found on many infectious bacteria, are primarily restricted to the IgG2 subclass. This phenomenon, known as isotype restriction, has led us and others to examine the prevalence of IgG2 deficiency among infection-prone individuals. IgG2 deficiency (below 3 SD of the age group mean) is fairly common among patients suffering from chronic bacterial infections and suggests the utility of IgG subclass measurements in evaluating such patients. However, we also describe exceptions to isotype restriction in human responses to carbohydrate antigens. Furthermore, we describe individuals who, while responding very poorly to carbohydrate antigens, have normal IgG2 levels for their age group. These findings indicate the complexity of IgG subclass regulation and suggest that evaluation of infection-prone individuals should include measurements of both IgG subclasses and antibodies to carbohydrate antigens such as phosphocholine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282712

Source DB:  PubMed          Journal:  Diagn Clin Immunol        ISSN: 0895-0458


  14 in total

1.  Influence of smoking and race on immunoglobulin G subclass concentrations in early-onset periodontitis patients.

Authors:  S M Quinn; J B Zhang; J C Gunsolley; J G Schenkein; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals.

Authors:  H Lu; M Wang; J C Gunsolley; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

3.  Contribution of murine IgG Fc regions to antibody binding to the capsule of Burkholderia pseudomallei.

Authors:  Michael J Dillon; Rachael A Loban; Dana E Reed; Peter Thorkildson; Kathryn J Pflughoeft; Sujata G Pandit; Paul J Brett; Mary N Burtnick; David P AuCoin
Journal:  Virulence       Date:  2016-04-20       Impact factor: 5.882

4.  Human IgG subclass responses and subclass restriction to Schistosoma mansoni egg antigens.

Authors:  J G Langley; H C Kariuki; A P Hammersley; J H Ouma; A E Butterworth; D W Dunne
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

Review 5.  Division of labor during primary humoral immunity.

Authors:  Cristina L Swanson; Roberta Pelanda; Raul M Torres
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

6.  Lack of IgG4 antibody response to carbohydrate antigens in patients with lymphatic filariasis.

Authors:  R B Lal; R R Dhawan; J J Tarrand; E M Ayoub; E A Ottesen
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

7.  IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL.

Authors:  Roland Fiskesund; Jun Su; Ivana Bulatovic; Max Vikström; Ulf de Faire; Johan Frostegård
Journal:  Results Immunol       Date:  2012-01-08

8.  Immunoglobulin class and subclass distribution of antibodies reactive with the immunodominant antigen of Actinobacillus actinomycetemcomitans serotype b.

Authors:  H Lu; J V Califano; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

Review 9.  Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis.

Authors:  Paul R J Ames; Mira Merashli; Tommaso Bucci; Daniele Pastori; Pasquale Pignatelli; Alessia Arcaro; Fabrizio Gentile
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

10.  IgG subclass and heavy chain domains contribute to binding and protection by mAbs to the poly γ-D-glutamic acid capsular antigen of Bacillus anthracis.

Authors:  Maria Hovenden; Mark A Hubbard; David P Aucoin; Peter Thorkildson; Dana E Reed; William H Welch; C Rick Lyons; Julie A Lovchik; Thomas R Kozel
Journal:  PLoS Pathog       Date:  2013-04-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.